Symbol="GERN"
AssetType="Common Stock"
Name="Geron Corporation"
Description="Geron Corporation, an advanced stage clinical biopharmaceutical company, focuses on the development and commercialization of therapies for myeloid hematologic neoplasms. The company is headquartered in Foster City, California."
CIK="886744"
Exchange="NASDAQ"
Currency="USD"
Country="USA"
Sector="LIFE SCIENCES"
Industry="PHARMACEUTICAL PREPARATIONS"
Address="149 COMMONWEALTH DRIVE, SUITE 2070, MENLO PARK, CA, US"
FiscalYearEnd="December"
LatestQuarter="2023-06-30"
MarketCapitalization="1292726000"
EBITDA="-173563008"
PERatio="None"
PEGRatio="-2.38"
BookValue="0.572"
DividendPerShare="0"
DividendYield="0"
EPS="-0.37"
RevenuePerShareTTM="0.001"
ProfitMargin="0"
OperatingMarginTTM="-386.54"
ReturnOnAssetsTTM="-0.333"
ReturnOnEquityTTM="-0.777"
RevenueTTM="450000"
GrossProfitTTM="-93668000"
DilutedEPSTTM="-0.37"
QuarterlyEarningsGrowthYOY="0"
QuarterlyRevenueGrowthYOY="-0.603"
AnalystTargetPrice="4.83"
TrailingPE="-"
ForwardPE="-"
PriceToSalesRatioTTM="571.98"
PriceToBookRatio="8.28"
EVToRevenue="493.55"
EVToEBITDA="-6.08"
Beta="0.859"
num_52WeekHigh="3.84"
num_52WeekLow="1.95"
num_50DayMovingAverage="3.008"
num_200DayMovingAverage="2.756"
SharesOutstanding="523371000"
DividendDate="None"
ExDividendDate="None"
symbol="GERN"
open="2.33"
high="2.52"
low="2.31"
price="2.47"
volume="6464775.00"
latest_trading_day="2023-08-25"
previous_close="2.31"
change="0.16"
change_percent="6.9264%"
aroon_positive_momentum_days="0"
aroon_negative_momentum_days="39"
trend_strength="Absent or Weak Trend"
buying_signal="Strong Sell Signal"
volume_analysis="Target Volume"
value_analysis="Expected Range"
Aroon_change="FALSE"
Aroon_momentum="61"
Volume_recent_avg="5721884"
Change_recent_avg="0.01"
Delta_recent_avg="0.15"
Variance_recent_avg="0.08"
Change_ratio_recent_avg="-0.17"
RSI_change="FALSE"
ADX_change="FALSE"

event="FALSE"
Aroon_signal="negative"
Aroon_change="FALSE"
Aroon_momentum_positive="61"
Aroon_momentum_negative="39"
image_negative_thumbnail_id_1="1144"
image_negative_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Negative_Landscape_0177.jpeg"
image_negative_thumbnail_id_2="130"
image_negative_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/05/MI_Finance_Negative_Landscape_0046.jpeg"
image_neutral_thumbnail_id_1="589"
image_neutral_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0010.jpeg"
image_neutral_thumbnail_id_2="547"
image_neutral_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Neutral_Landscape_0052.jpeg"
image_positive_thumbnail_id_1="664"
image_positive_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0044.jpeg"
image_positive_thumbnail_id_2="623"
image_positive_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Positive_Landscape_0085.jpeg"
image_professor_thumbnail_id_1="1170"
image_professor_url_1="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0004.jpeg"
image_professor_thumbnail_id_2="1194"
image_professor_url_2="https://hehge.com/wp-content/uploads/sites/16/2023/06/MI_Finance_Professor_Landscape_0028.jpeg"
